- Investing Ideas
- Global Pharmaceuticals & Biotech Breakout Stocks
Global Pharmaceuticals & Biotech Breakout Stocks
Results
14
Stocks where the price continues to rise after more than a year of consistent gains.
14 companies
IQVIA Holdings
Market Cap: US$40.5b
Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
IQV
US$247.56
7D
24.7%
1Y
29.2%
Avantor
Market Cap: US$8.5b
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
AVTR
US$14.38
7D
31.3%
1Y
4.2%
Kiniksa Pharmaceuticals International
Market Cap: US$6.2b
A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
KNSA
US$80.92
7D
29.6%
1Y
169.2%
Forte Biosciences
Market Cap: US$1.9b
Operates as a clinical-stage biopharmaceutical company in the United States.
FBRX
US$76.53
7D
35.1%
1Y
651.4%
iX Biopharma
Market Cap: S$566.4m
A specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, the United States, China, and Australia.
42C
S$0.52
7D
30.0%
1Y
2,636.8%
GlaxoSmithKlineE
Market Cap: ج.م16.7b
Engages in production of pharmaceutical chemicals.
BIOC
ج.م199.80
7D
64.2%
1Y
369.1%
AFT Pharmaceuticals
Market Cap: NZ$505.5m
Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$4.82
7D
21.1%
1Y
76.6%
Vitrafy Life Sciences
Market Cap: AU$266.7m
Engages in the research, development, and commercialization of cryopreservation solutions in Australia.
VFY
AU$3.50
7D
24.6%
1Y
113.4%
Entera Bio
Market Cap: US$160.7m
A clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally.
ENTX
US$3.00
7D
47.8%
1Y
48.5%
Intravenous Infusions
Market Cap: GH₵216.8m
A pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region.
IIL
GH₵0.86
7D
56.4%
1Y
2,050.0%
Panacea Life Sciences Holdings
Market Cap: US$5.4m
Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.
PLSH
US$0.09
7D
20.0%
1Y
177.8%
Blueberries Medical
Market Cap: CA$7.4m
A consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia.
BBM
CA$0.02
7D
33.3%
1Y
33.3%
Cannabis Global
Market Cap: US$359.0k
Focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body.
CBGL
US$0.0001
7D
9,900.0%
1Y
9,900.0%
ObsEva
Market Cap: US$11.7k
A biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health.
OBSE.F
US$0.0001
7D
9,900.0%
1Y
0%